Levosimendan’s specific characteristics, such as its moderate lipophilic nature, potential for direct interactions with cancer cells in the small intestine, impact on Ca2+ dynamics, and lack of P-gp substrate activity, may contribute to its enhanced anti-cancer efficacy [77,78]. Here, PGP is linked to cancer.